BlackRock Health Sciences Term Trust
BMEZ- Exchange
- NYSE
- SEC CIK
- 0001785971
No open-market purchases or sales by BlackRock Health Sciences Term Trust insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $255.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by BlackRock Health Sciences Term Trust insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for BlackRock Health Sciences Term Trust, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Xie H Erin | Other: Portfolio Manager | 0 | Feb 3, 2026 | 1 |
| Liu Xiang | Other: Portfolio Manager | 0 | Feb 3, 2026 | 1 |
| Fairbairn Robert W | Director | 0Indirect | Dec 22, 2025 | 1 |
| Saba Capital Management, L.P. | 10% Owner | 0Indirect | Apr 22, 2025 | 0 |
| Weinstein Boaz | 10% Owner | 0Indirect | Apr 22, 2025 | 0 |
| McClements Kyle | Other: Portfolio Manager | 3,664 | Feb 4, 2025 | 0 |
| Accettella Christopher | Other: Portfolio Manager | 4,509 | Feb 4, 2025 | 0 |
| Lee Jeffrey Gene | Other: Portfolio Manager | – | Feb 2, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 (view filing)11:07 AM ET | Sep 30 | 1 day | Saba Capital Management, L.P. and 1 other10% Owner | PPurchase | +8.01K | $15.84 | +$126.9K | 0.0%20.7M after | |
| Oct 3, 2024 (view filing)1:02 PM ET | Oct 1 | 2 days | Saba Capital Management, L.P. and 1 other10% Owner | PPurchase | +9.53K | $15.79 | +$150.4K | 0.0%20.7M after | |
| Oct 4, 2024 (view filing) | Jan 11 | 267 daysLate | Accettella ChristopherOther: Portfolio Manager | PPurchase | +1.19K | $15.17 | +$18.1K | +41.3%4.07K after | |
| Oct 15, 2024 (view filing)10:01 AM ET | Oct 14 | 1 day | Saba Capital Management, L.P. and 1 other10% Owner | PPurchase | +15.3K | $15.87 | +$242.5K | +0.1%20.7M after | |
| Oct 17, 2024 (view filing)10:54 AM ET | Oct 15-16 | 2 days | Saba Capital Management, L.P. and 1 other10% Owner | PPurchase | +64.7K | $15.81 | +$1.02M | +0.3%20.8M after | 2 lots |
| Dec 22, 2025 (view filing) | Dec 18-19 | 4 days | Fairbairn Robert WDirector | SSale | −10.3K | $14.98 | −$154.2K | −100.0%0 after | 2 lots |
| Dec 22, 2025 (view filing) | Dec 18-19 | 4 days | Fairbairn Robert WDirector | SSale | −10.3K | $14.98 | −$154.2K | −100.0%0 after | 2 lots |